Hyperoxaluria Fund Grant

Hyperoxaluria Fund Grant

Status: ACTIVE
Funder: Healthwell Foundation
Amount: Up to US $8,000
Last Updated: February 13, 2026

Summary

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

Overview

Note: If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. What We Do Our Mission: To reduce financial barriers to care for underinsured patients with chronic or life-altering diseases. The HealthWell Foundation is a leading independent non-profit dedicated to improving access to health care for America’s underinsured. When health insurance is not enough, we fill the gap by assisting with copays, premiums, deductibles and out-of-pocket expenses. In 2025, we awarded more than $1.1 billion in grants through our Disease Funds, and since 2004 we have helped more than 1,390,000 patients afford essential treatments and medications. HealthWell is recognized as one of America’s most efficient charities — 100 percent of every dollar donated goes directly to patient grants and services. We provide financial assistance to help with: Prescription copaysHealth insurance premiums, deductibles and coinsurancePediatric treatment costsTravel costsBehavioral health services Our Vision: To ensure that no patient goes without health care because they cannot afford it. Hyperoxaluria About Hyperoxaluria According to the Oxalosis and Hyperoxaluria Foundation, hyperoxaluria occurs when a person’s urine contains too much oxalate, a natural chemical in the body which is also found in certain types of food. High levels of oxalate are toxic because oxalate cannot be broken down by the human body and accumulates in the kidneys. Hyperoxaluria can be caused by a genetic disorder, eating too many oxalate-rich foods or an intestinal disease. There are two forms of hyperoxaluria: Primary hyperoxaluria (PH) is a family of ultra-rare, life-threatening genetic disorders that cause complications in the kidneys. There are 3 types of PH: type 1 (PH1), type 2 (PH2), and type 3 (PH3), each resulting from a mutation in one of three different genes. These genetic mutations all cause enzyme deficiencies that cause the overproduction of oxalate.Enteric hyperoxaluria (EH) is a common occurrence in the setting of fat malabsorption, usually due to intestinal resection or intestinal bypass surgery. Enhanced intestinal absorption of dietary oxalate leads to elevated oxalate excretion. Abnormal production and accumulation of oxalate can lead to recurrent kidney stones, nephrocalcinosis and chronic kidney disease. Over time, the buildup of oxalate in the kidneys can lead to kidney failure. As kidney function worsens, the kidneys are no longer able to eliminate oxalate and oxalate crystals form throughout the body. The damage happens at different rates in different people and it can be permanent, this is called oxalosis. The deposits can occur in multiple organs in the body, including the eyes, bones, skin and heart. In some cases, hyperoxaluria can result in the need for kidney transplantation or a dual liver-kidney transplant. Early diagnosis and treatment are important to the long-term health of the kidneys. Fund Definition Assistance with the prescription drugs and biologics used in the treatment and management of Hyperoxaluria. Grant Utilization HealthWell estimates that patients use an average of $3,200 during their 12-month grant period for this disease area. Assistance Type Prescription Drug CopayInsurance premium (Medicare Part B only) Maximum Award Level $8,000 Pharmacy Card Fund Yes Minimum Copay Reimbursement Amount None Minimum Premium Reimbursement Amount None Treatments Covered ChlorothiazideChlorthalidoneChlorthalidone AvpakDibasic/na PhosDiurilHydrochlorothiazideIndapamideK Phos MonobasicK Phos/na PhosK-phos NeutralK-phos No. 2K-phos OriginalMethyclothiazideMetolazoneMonobasicOxlumoPhos-nakPhospha 250 NeutralPotassium CitratePotassium Citrate MonohydratePyridoxine HclRivflozaUrocit-kUrocit-k 10Urocit-k 5Vitamin B6 (non Otc)

Eligibility

You can learn more about this opportunity by visiting the funder's website. Do I Qualify?HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:You are being treated for Hyperoxaluria.We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.You have insurance and it covers your medication.To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B.Your income falls within our guidelines.HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level.Household Income Limit500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.You are receiving treatment in the United States.Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

Ineligibility

The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.